RecruitingNCT02797561

Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions

A Multicenter, Prospective Cohort to Evaluate the Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions


Sponsor

Seung-Jung Park

Enrollment

1,000 participants

Start Date

Jul 25, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to evaluate the effect of FFR (Fractional flow reserve) guided Percutaneous Coronary Intervention in coronary tandem lesions.


Eligibility

Min Age: 19 Years

Inclusion Criteria2

  • Tandem lesion evaluated by FFR
  • Written consent

Exclusion Criteria8

  • TIMI flow \< 3
  • Grafted vessel
  • Left ventricular ejection fraction \< 30%
  • Severe calcification and/or severe tortuosity
  • Uncontrolled coronary spasm
  • Life expectancy \< 2 years
  • Planned high risk surgery
  • Pregnancy or breast-feeding

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHER5 year Follow-up

Locations(14)

Asan Medical Center

Seoul, Songpa-gu, South Korea

Soon Chun Hyang University Hospital Bucheon

Bucheon-si, South Korea

Gangwon National Univ. Hospital

Chuncheon, South Korea

Daegu Catholic University Medical Center

Daegu, South Korea

Keimyung University Dongsan Medical Center

Daegu, South Korea

Chungnam National University Hospital

Daejeon, South Korea

Gangneung Asan Hospital

Gangneung, South Korea

Inje University Ilsan Paik Hospital

Ilsan, South Korea

Bundang CHA Hospital

Seongnam, South Korea

Seoul National University Bundang hospital

Seongnam, South Korea

Kangbuk Samsung Hospital

Seoul, South Korea

Seoul National University hospital

Seoul, South Korea

Wonju Severance Christian Hospital

Wŏnju, South Korea

Pusan National University Yangsan Hospital

Yangsan, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02797561


Related Trials